170 related articles for article (PubMed ID: 2642485)
1. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.
Pasquali R; Antenucci D; Casimirri F; Venturoli S; Paradisi R; Fabbri R; Balestra V; Melchionda N; Barbara L
J Clin Endocrinol Metab; 1989 Jan; 68(1):173-9. PubMed ID: 2642485
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
3. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
[TBL] [Abstract][Full Text] [Related]
4. 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
Jakubowicz DJ; Nestler JE
J Clin Endocrinol Metab; 1997 Feb; 82(2):556-60. PubMed ID: 9024253
[TBL] [Abstract][Full Text] [Related]
5. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
Imani B; Eijkemans MJ; de Jong FH; Payne NN; Bouchard P; Giudice LC; Fauser BC
J Clin Endocrinol Metab; 2000 Feb; 85(2):676-82. PubMed ID: 10690875
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
7. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.
Guzick DS; Wing R; Smith D; Berga SL; Winters SJ
Fertil Steril; 1994 Apr; 61(4):598-604. PubMed ID: 8150098
[TBL] [Abstract][Full Text] [Related]
8. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
10. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women.
Bützow TL; Lehtovirta M; Siegberg R; Hovatta O; Koistinen R; Seppäla M; Apter D
J Clin Endocrinol Metab; 2000 Sep; 85(9):3271-5. PubMed ID: 10999821
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical characteristics of women with menstrual disturbance.
Shen SY; Huang SY; Hsieh CH; Hsu MI; Cheng CY; Hsu CS
Taiwan J Obstet Gynecol; 2014 Jun; 53(2):178-82. PubMed ID: 25017262
[TBL] [Abstract][Full Text] [Related]
12. The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.
Pasquali R; Casimirri F; Balestra V; Flamia R; Melchionda N; Fabbri R; Barbara L
J Endocrinol Invest; 1991 Nov; 14(10):839-46. PubMed ID: 1802922
[TBL] [Abstract][Full Text] [Related]
13. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.
van Dam EW; Roelfsema F; Veldhuis JD; Hogendoorn S; Westenberg J; Helmerhorst FM; Frölich M; Krans HM; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E615-20. PubMed ID: 14678951
[TBL] [Abstract][Full Text] [Related]
14. Endocrine comparison of obese menstruating and amenorrheic women.
Zhang YW; Stern B; Rebar RW
J Clin Endocrinol Metab; 1984 Jun; 58(6):1077-83. PubMed ID: 6427258
[TBL] [Abstract][Full Text] [Related]
15. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovaries in Hirsute women with normal menses.
Carmina E; Lobo RA
Am J Med; 2001 Dec; 111(8):602-6. PubMed ID: 11755502
[TBL] [Abstract][Full Text] [Related]
17. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
Moran LJ; Noakes M; Clifton PM; Norman RJ
J Clin Endocrinol Metab; 2007 Oct; 92(10):3796-802. PubMed ID: 17652213
[TBL] [Abstract][Full Text] [Related]
18. Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings.
Dunaif A; Green G; Phelps RG; Lebwohl M; Futterweit W; Lewy L
J Clin Endocrinol Metab; 1991 Sep; 73(3):590-5. PubMed ID: 1874935
[TBL] [Abstract][Full Text] [Related]
19. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
